EPS growth is an important number as it indicates the future prospects of Nuvectra Corporation. The EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been 67.10 % over the last twelve months. The higher the EPS growth rate, the higher the value that is added to shareholders and a good reflection on the performance of the management at Nuvectra Corporation.



Nuvectra Corporation is in the healthcare sector and is part of the medical devices industry. The company CEO is Scott F. Drees. Nuvectra Corp is a medical device company in the United States. It manufactures devices to address chronic neurological disorders. The company has two reportable segments namely Nuvectra and NeuroNexus.

Previous Intraday Performance:

The NVTR shares had a previous change of -7.87% which opened at 20.58 and closed at 18.96. It moved to an intraday high of 20.80 and a low of 18.27.

SeekingAlpha:  Best Performing Stocks YTD 2018

Historical Performance:

Over the last five trading days, NVTR shares returned -0.32% and in the past 30 trading days it returned -6.83%. Over three months, it changed -15.28%. In one year it has changed 107.44% and within that year its 52-week high was 25.17 and its 52-week low was 7.60. NVTR stock is 149.47% above its 52 Week Low.

Our calculations result in a 200 day moving average of 17.60 and a 50 day moving average of 20.45. Right now, NVTR stock is trading 7.76% above its 200 day moving average.

SeekingAlpha:  Best Performing Stocks YTD 2018

Liquidity:

The company has a market cap of $333.9m with 17.6m shares outstanding and a float of 17.1m shares. Trading volume was 216,287 shares and has experienced an average volume of 182,781 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.

Earnings:

The last annual reported EPS for Nuvectra Corporation was -4.22 which ended on 31st of December 2017. Based on 2 analyst estimates, the consensus EPS for the next quarter is -0.86.

Below was the last reported quarterly earnings per share:
09-30-2018:  -0.87
06-30-2018:  -0.83
03-31-2018:  -0.84
12-31-2017:  -0.80



Indicators Also to Watch:

Based on the latest filings, there is 96.20% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.

I calculated the beta to be -0.17

PR Newswire:  Secoo Announced Unaudited 2018 Q3 Financial Report, GMV Increased 57.4%

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is -54.94%, return on assets is -34.04%, profit margin is -86.32%, price-to-sales is 7.26 and price-to-book is 3.20.

Company Score Card:

Results are out of six:
 2  : Growth Expectations Result
 4  : Financial Safety Result
 0  : Past Performance Result
 1  : Valuation Result
 0  : Dividend Safety Result
 1  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here